| Identification | More | [Name]
PROTOPANAXDIOL | [CAS]
30636-90-9 | [Synonyms]
PROTOPANAXDIOL | [Molecular Formula]
C30H52O3 | [MDL Number]
MFCD01861516 | [MOL File]
30636-90-9.mol | [Molecular Weight]
460.738 |
| Chemical Properties | Back Directory | [Melting point ]
197-200 °C | [Boiling point ]
559.5±40.0 °C(Predicted) | [density ]
1.036 | [storage temp. ]
-20°C Freezer | [solubility ]
Chloroform (Slightly), Methanol (Slightly), Pyridine (Slightly) | [form ]
Solid | [pka]
14.96±0.70(Predicted) | [color ]
White | [Detection Methods]
NMR,HPLC | [InChIKey]
PYXFVCFISTUSOO-PXTFUGJUNA-N | [SMILES]
[C@]12(CC[C@@]3([H])C(C)(C)[C@@H](O)CC[C@]3(C)[C@@]1([H])C[C@@H](O)[C@]1([H])[C@H](CC[C@@]21C)[C@](C)(O)CC/C=C(/C)\C)C |&1:0,3,8,12,14,17,19,21,24,26,r| | [CAS DataBase Reference]
30636-90-9(CAS DataBase Reference) |
| Hazard Information | Back Directory | [Definition]
ChEBI: A diastereomer of protopanaxadiol in which the 20-hydroxy substituent has been introduced at the pro-S position. | [Chemical Properties]
White crystalline powder, soluble in organic solvents such as methanol, ethanol, and DMSO, derived from ginseng. | [Uses]
(20S)-Protopanaxadiol is used in the treatment of cerebral ischemic injury and the reversal of oxidative stress. A novel class of AMP-activated protein kinase (AMPK) inhibitors affecting glucose and lipid metabolism. | [target]
p53 | p21 | Bcl-2/Bax | P-gp | Caspase | γH2Ax |
|
|